Category Archives: Events

Europe: Expectations High for Rare Disease Day

Next week Europe will celebrate Rare Disease Day. This is an interesting example – one might almost say a rare example – of a successful attempt by a European interest group to capture public attention. It is now an annual awareness-raising event co-ordinated by the European rare diseases lobby group, EURORDIS. For this year’s celebration, […]
Also posted in Europe, Global, Guest Blog, Orphan Drugs | Tagged , , , , | Leave a comment

HBA's 2014 Woman of the Year: Broadening the Base

HBA’s 2014 Woman of the Year:  Broadening the Base To mark its 25th year in recognizing female leadership in the tough competitive ranks of biopharma, the Healthcare Businesswomen’s Association [HBA] is opting for a breakout triple play.  When the group convenes on May 1 in New York for its annual Woman of the Year [WOTY] […]
Also posted in healthcare, leadership, People | Tagged , , , , , | Leave a comment

J.P. Morgan: Pharma's Agenda for 2014

Presenters at the 32nd annual J.P. Morgan Healthcare Conference talked up value-based pricing, emerging market strategies, complex generics and new technology, from bedside devices and genetic sequencers to first-in-class mechanisms of action. Company executives honed in on their chosen therapeutic areas and made the case for aggressive spending in R&D to bring the next generation […]
Also posted in Biotech, Corporate Responsibility, Deals, Emerging Markets, Europe, FDA, Gene therapy, Global, IP, leadership, Legal, Manufacturing, Market Access, Orphan Drugs, People, pricing, R&D, Regulatory, Safety, Sales, Strategy, Technology | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Russian Innovation: A Higher Mark

The pursuit of excellence in biopharmaceutical innovation in Russia has never had a sponsor—until now. Prix Galien International, a global network of Nobel laureates in medicines, established its 18th country beachhead in Moscow earlier this year, culminating in a historic first: an October 24 awards dinner to recognize the best in new drug research as […]
Also posted in E-Media, R&D, Strategy | Tagged , , , , , , , , | Leave a comment

Nano Tech: Big Stakes in Small Things

Nano Tech: Big Stakes in Small Things New and emerging technologies are noteworthy not simply for the excellent science behind them but also for the way they expose those raw edges of the industry’s business model. In biopharma today, disruptive changes to the model are being driven by two forces. The first is advances in […]
Also posted in Regulatory, Technology | Tagged , , | Leave a comment
  • Categories

  • Meta